Therapeutics: Kruppel-like factor 4 (KLF4; EZF); galectin-3 (LGALS3)

Cardiovascular disease

INDICATION: Atherosclerosis

Cell culture and mouse studies suggest inhibiting KLF4 could help treat atherosclerosis. In atherosclerotic

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE